Apollomics, Inc. (APLM) vs ImageneBio Inc (IMA)
A side-by-side comparison of Apollomics, Inc. and ImageneBio Inc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
APLM
Apollomics, Inc.
$25.00HealthcareDelayed quote: Oct 6, 2026, 10:04 AM EDT
IMA
ImageneBio Inc
$4.70HealthcareDelayed quote: Oct 6, 2026, 10:01 AM EDT
Total return — APLM vs IMA
growth of $100 · dividends reinvested · last 5yAPLM -97.6% (-52.8%/yr)IMA -97.4% (-51.9%/yr)IMA compounded faster over this window
APLM IMA
APLM vs IMA: by the numbers
- •APLM is the larger company ($55M vs $53M market cap).
- •Both run net losses; APLM's is the smaller (-128.69% vs -5668.62% net margin).
Metrics side by side
Valuation
| Metric | APLM | IMA |
|---|---|---|
| P/B ratio | N/A | 0.37 |
Profitability
| Metric | APLM | IMA |
|---|---|---|
| Gross margin | 97.00% | -29.12% |
| Operating margin | -111.45% | -6056.37% |
| Net margin | -128.69% | -5668.62% |
| ROE | N/A | -36.94% |
| ROIC | -2441.49% | -40.53% |
Growth (annualized)
| Metric | APLM | IMA |
|---|---|---|
| Revenue CAGR (5Y) | 35.84% | N/A |
| Total return CAGR (5Y) | N/A | -50.73% |
Go deeper
Dig into the metrics
Apollomics ROEImageneBio ROEApollomics operating marginImageneBio operating marginApollomics revenue growthImageneBio revenue growthApollomics free cash flowImageneBio free cash flow
Apollomics & ImageneBio appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.